Frontlight ResearchEarly access
Ovarian cancer trials in China
185 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ChinaAdebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
- Where
- Fuzhou
- Age
- 18 years to 70 years
- People
- 37
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06600841 - Phase 2Taking peopleHS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
- Where
- Beijing, Changchun, Changsha, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hanzhou, Harbin, Hefei, Jinan, Kunming, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi’an, Xinjiang, Zhengzhou
- Age
- 18 years and over
- People
- 460
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06014190 - No phaseTaking peopleThe Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 198
- Run by
- Tongji Hospital
See details and how to joinNCT06556342 - No phaseNot yet taking people in ChinaExosome-based OCS Scores for Predicting Ovarian Cancer Recurrence
- Where
- Beijing
- Age
- 18 years and over
- People
- 509
- Run by
- Lei Li
See details and how to joinNCT06558019 - Phase 2Not yet taking people in ChinaFluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06552858 - Phase 3Taking peopleSHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
- Where
- Beijing, Hangzhou
- Age
- 18 years and over
- People
- 440
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06394492 - Phase 2Not yet taking people in ChinaSecondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
- Where
- Shanghai
- Age
- 18 years and over
- People
- 94
- Run by
- Fudan University
See details and how to joinNCT06544460 - Phase 2/3Not yet taking people in ChinaPlasmodium Immunotherapy for Advanced Ovarian Cancer
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 30
- Run by
- CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
See details and how to joinNCT05924776 - No phaseNot yet taking people in ChinaThe Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
- Where
- Suzhou
- Age
- 18 years to 80 years
- People
- 80
- Run by
- Geneplus-Beijing Co. Ltd.
See details and how to joinNCT06283875 - Phase 2/3Taking peopleTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Where
- Guanzhou
- Age
- 18 years and over
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739 - Phase 1/2Taking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - Phase 1Taking peopleCLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05410717 - Phase 2Taking peopleEfbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
- Where
- Changsha, Hangzhou, Jinan, Nanjing, Qingdao, Taiyuan
- Age
- 18 years to 70 years
- People
- 83
- Run by
- Shandong University
See details and how to joinNCT06251947 - Phase 1/2Taking peopleSafety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
- Where
- Hefei
- Age
- 18 years to 70 years
- People
- 28
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT06395844 - Phase 2/3Taking peopleApplication of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC
- Where
- Wenzhou
- Age
- 18 years to 70 years
- People
- 10
- Run by
- Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06341907 - No phaseTaking peopleLiquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )
- Where
- Guangzhou, Shanghai, Shenyang
- Age
- 40 years to 75 years
- People
- 168
- Run by
- Fudan University
See details and how to joinNCT06249308 - Phase 2Taking peopleAdebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.
- Where
- Fujian
- Age
- 18 years to 70 years
- People
- 37
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05753826 - Phase 1Taking peopleA Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
- Where
- Wuhu
- Age
- 18 years and over
- People
- 36
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06215950 - No phaseTaking peopleBespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 139
- Run by
- Fudan University
See details and how to joinNCT05446545 - No phaseTaking peopleShanghai Ovarian Cancer and Family Care Project
- Where
- Shanghai
- Age
- 18 years and over
- People
- 3,546
- Run by
- Shanghai First Maternity and Infant Hospital
See details and how to joinNCT06118307 - Phase 2Not yet taking people in ChinaFirst-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 44
- Run by
- Sun Yat-sen University
See details and how to joinNCT06063070 - No phaseTaking peopleA Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 200
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05251883 - Phase 3Taking peopleTC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
- Where
- Jinan
- Age
- 14 years to 65 years
- People
- 129
- Run by
- Beihua Kong
See details and how to joinNCT02429687 - Phase 3Taking peopleTC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
- Where
- Jinan
- Age
- 14 years to 65 years
- People
- 132
- Run by
- Beihua Kong
See details and how to joinNCT02429700 - No phaseNot yet taking people in ChinaCytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 140
- Run by
- Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05633199